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The interaction of small heat shock proteins (sHSPs) with
the actin cytoskeleton has been described and some mem-
bers of this family, e.g. chicken and murine HSP25
(HSP27), inhibit the polymerization of actin in vitro. To
analyse the molecular basis of this interaction, we syn-
thesized a set of overlapping peptides covering the com-
plete sequence of murine HSP25 and tested the effect of
these peptides on actin polymerization in vitro by fluores-
cence spectroscopy and electron microscopy. Two peptides
comprising the sequences W43 to R57 (peptide 6) and I92
to N106 (peptide 11) of HSP25 were found to be potent
inhibitors of actin polymerization. Phosphorylation of
N-terminally extended peptide 11 at serine residues known
to be phosphorylated in vivo resulted in decline of their
inhibitory activity. Interestingly, peptides derived from the
homologous peptide 11 sequence of murine aB-crystallin
showed the same behaviour. The results suggest that both
HSP25 and aB-crystallin have the potential to inhibit
actin polymerization and that this activity is regulated by
phosphorylation.
Keywords: actin polymerization; electron microscopy;
fluorescence spectroscopy; small heat shock proteins;
phosphorylation.
Heat shock and other environmental and pathophysiologic
stresses stimulate the synthesis of heat shock proteins
(HSPs). These proteins enable cells to survive and recover
from stressful conditions by as yet incompletely understood
mechanisms. Small heat shock proteins (sHSPs) constitute
one of the major heat shock protein families and are
characterized by a molecular mass of 15±40 kDa. They
share a homologous sequence of about 90 amino acids,
called the `a-crystallin domain' because of its similarity
with a sequence motif in the major eye lens protein
aB-crystallin [1]. For sHSPs and aB-crystallin, which was
also characterized as a sHSP [2], similar structural and
functional properties have been described (reviewed in
[3,4]). sHSPs and aB-crystallin have the ability to form
multimeric complexes with a molecular mass of up to
< 800 kDa [5±8]. They occur in unphosphorylated and
phosphorylated isoforms [9±13], and show chaperoning
activity [14,15]. Furthermore, interactions with the cyto-
skeleton have been observed. For aB-crystallin interactions
with actin and intermediate filament proteins have been
described [16±21], while HSP25 appears to interact
primarily with actin filaments [8,21±27]. (In this paper
the sHSP of mouse, chicken and human is referred to as
HSP25. Other names used for this protein are HSP27 or
HSP28.) HSP25 from chicken, mouse and yeast has been
identified as inhibitor of actin polymerization in vitro
[8,22,23]. The unphosphorylated monomer is the active
form in this process, whereas phosphorylated monomers
and high molecular weight complexes are inactive [8].
Several of the studies cited above and others support the
idea that an interaction of sHSPs with actin also occurs
in vivo. Overexpression of HSP25 was shown to stabilize
microfilaments against deleterious effects of hyperthermia
and cytochalasin D in murine NIH/3T3 cells [24] and to
increase the concentration of F-actin at the cell cortex and
the pinocytotic activity in Chinese hamster cell lines [25].
HSP25 was found to colocalize, depending on the devel-
opmental stage, with the actin cytoskeleton in rat Sertoli
cells [26] and with the I-band of myofibrils in cardiomyo-
cytes of rat and human heart [21]. Furthermore, over-
expression of HSP25 influenced the organization of cortical
actin in bovine endothelial cell lines [27]. In several reports
it was shown that the association of HSP25 with actin was
modulated by phosphorylation of the protein [8,25,27±30].
As the microfilament network is an early target of cellular
stress and different signal transduction pathways, it is likely
that sHSPs may contribute to the regulation of actin
dynamics under normal and stressful conditions.
To gain more information on the interaction between
sHSPs and actin we tested a set of overlapping peptides
derived from the murine HSP25 sequence [31] for their
ability to inhibit actin polymerization. Two of the 22
HSP25-derived peptides studied were found to be potent
inhibitors of actin polymerization in vitro. N-terminal
extension and phosphorylation at serine residues of these
peptides known to be phosphorylated in vivo modulated
their inhibitory activity. A similar behaviour was observed
for homologous peptides derived from the murine
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aB-crystallin sequence. The data elucidate for the first time
part of the molecular mechanism underlying the interaction
of HSP25 and aB-crystallin with actin.
E X P E R I M E N T A L P R O C E D U R E S
Peptide synthesis
Peptides were synthesized by multiple solid phase peptide
synthesis using the Fmoc chemistry procedure [32] on a
PSSM-8 synthesizer (Shimadzu, Japan). Tentagel S RAM
resin (RAPP Polymere GmbH, Germany) was used as
carrier and 30% piperidine/dimethylformamide was used
for Fmoc deprotection. All couplings were performed
with O-(benzotriazol-1-yl)N,N 0,N 0-tetramethyluronium tetra-
fluoroborate/1-hydroxybenzotriazole/N-methylmorpholine in
dimethylformamide. Fmoc-Ser(PO(Obzl)-OH (Novabio-
chem, Switzerland) was used for the synthesis of phos-
phoserine peptides. After synthesis all peptides were
acetylated, cleaved from the resin by trifluoracetic acid
and the resulting N-terminally acetylated peptide amides
were analysed by HPLC and purified up to 85±95% purity.
All peptides were characterized by MS using a MALDI I
mass spectrometer (Kratos, Manchester, UK) [33]. After
lyophilization peptides were stored at 220 8C. Before use,
peptides were dissolved in distilled water, and concentra-
tions were determined by quantitative amino acid analysis
using a Sykam Analysator (Sykam, Gilching, Germany).
Aliquots were used for determination of extinction
coefficients of all peptides by recording of UV spectra.
Preparation of pyrene actin
F-actin was prepared from rabbit muscle powder according
to the procedure of Pardee and Spudich [34] in buffer A
(2 mm Tris/HCl pH 8.0, 0.2 mm CaCl2, 0.2 mm Na2ATP,
1 mm NaN3). After extensive dialysis in buffer B (1 mm
NaHCO3 pH 7.6, 0.1 m KCl, 1 mm MgCl2, 0.1 mm CaCl2,
0.2 mm Na2ATP, 1 mm NaN3), the concentration of
actin was adjusted to 1 mg´mL21 using an extinction coef-
ficient of 2.66  104´m21´cm21 at 290 nm wavelength
[35]. Labelling was overnight with a freshly prepared
solution of N-(1-pyrene)iodoacetamide (Molecular Probes)
as described by Kouyama and Mihashi [36]. Labelled
F-actin was depolymerized by extensive dialysis against
buffer C (2 mm imidazole/HCl pH 7.0, 0.1 mm CaCl2,
0.2 mm Na2ATP, 1 mm dithiothreitol, 1 mm NaN3) and
centrifuged for 2 h at 150 000 g in a Beckman TLA 100.3
rotor (Beckman Instruments) to obtain purified labelled
G-actin in the supernatant.
Preparation of actin nuclei
Unlabelled F-actin was depolymerized by extensive dialysis
against buffer C and separated from traces of F-actin by
centrifugation for 2 h at 150 000 g in a Beckman TLA
100.3 rotor. Actin nuclei were prepared from the super-
natant according to the procedure described by Pollard
[35]. Briefly, 0.1 vol. of a 10  buffer D solution (100 mm
imidazole/HCl pH 7.0, 500 mm KCl) was added to
unlabelled G-actin (1.5 mg´mL21), polymerized overnight,
diluted to 0.5 mg´mL21 with buffer D and equilibrated for
at least 3 h before use in the polymerization assay.
Actin polymerization
Actin polymerization was measured by enhancement of
fluorescence of pyrene-labelled actin using a Shimadzu
RF5001PC spectrofluorometer (Shimadzu Europe GmbH,
Duisburg, Germany) equipped with a 150-W Xenon lamp
and a temperature-controlled sample compartment under
control of the rf software (Shimadzu). Fluorescence was
monitored at an excitation wavelength of 365 nm (5 nm
slit) and an emission wavelength of 407 nm (10 nm slit) for
10 min at 25 8C. If not mentioned otherwise, assay mix-
tures were prepared directly in the cuvette (Hellma micro-
cuvette, 3 mm light path) in a total volume of 60 mL in the
following manner: 5 mL labelled G-actin (final concentra-
tion 2 mm) and different amounts of peptides in 5 mL
distilled water were diluted into 44 mL buffer C and equi-
librated for 3 min at 25 8C in the spectrofluorometer. To
initialize polymerization, 1 mL actin nuclei and 5 mL of a
salt solution (600 mm KCl, 24 mm MgCl2) were added and
thoroughly mixed. Recording was started within 10 s after
addition of the latter. Under these conditions actin poly-
merization starts almost immediately and follows largely a
linear kinetics up to 15 min. Addition of nuclei alone could
not induce polymerization and addition of salt alone
resulted in an extended lag period of about 5 min
(Fig. 1A). For estimation of the stoichiometry of inhibition,
slopes were determined from linear regression of the curves
up to 5 min after start of the reaction, i.e. within the linear
range of the slopes. They were calculated as percentage of
inhibition of actin polymerization as compared to the
control.
Electron microscopy
In this assay, conditions of polymerization were modified,
in that nuclei were omitted in order to visualize only newly
formed actin filaments. Furthermore, mixtures were incu-
bated for 15 min before processing for electron microscopy
because of the prolonged lag-period in the absence of actin
nuclei (cf. Fig. 1A, curve 2). Samples were negatively
stained with 1% uranyl formate using the double carbon
film technique as described previously [7]. Micrographs
were taken with an EM 910 electron microscope (LEO,
Oberkochen, Germany) at 80 kV and a magnification
of 50 000.
R E S U L T S
Inhibition of actin polymerization by murine
HSP25-derived peptides
To identify HSP25-derived fragments which interact with
actin, a set of peptides was synthesized comprising the
entire murine HSP25 sequence (Table 1). The size of the
peptides ranged from 12 to 15 amino-acid residues with
overlapping stretches of five to seven residues. These
peptides were tested with respect to their ability to inhibit
actin polymerization in vitro in a spectrofluorometric assay
as described in Experimental procedures. When used at
20-fold molar excess over G-actin, only two peptides had
an inhibitory effect on actin polymerization: peptide 6
(W43-R57) and peptide 11 (I92-N106). All other peptides
had no influence under these conditions. The dependence of
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actin polymerization inhibition on the concentration of both
peptides is demonstrated in Fig. 1B±D. Fig. 1B shows
actin polymerization in the presence of varying amounts of
peptide 6 (molar ratios of peptide 6 to G-actin 4 : 1, 8 : 1,
12 : 1, 16 : 1; curves 2±5, respectively) in comparison with
the control without peptide 6 (curve 1). Fig. 1C shows a
similar experiment for peptide 11 (molar ratios of peptide
11 to G-actin 0.5 : 1, 1 : 1, 2 : 1, 4 : 1, 6 : 1, 8 : 1, 10 : 1;
curves 2±8, respectively) in comparison with the control
without peptide 11 (curve 1). In Fig. 1D the percentage
inhibition (compared with the controls) was calculated from
Fig. 1. Influence of HSP25 peptides on actin polymerization analysed by fluorescence spectroscopy. (A) Actin polymerization (1.2 mm G-
actin) in the presence (curve 1) or absence (curve 2) of 0.1 mm actin nuclei. (B) Actin polymerization in the presence of 4-, 8-, 12- and 16-fold molar
excess of peptide 6 over G-actin (2 mm) (curves 2±5, respectively; curve 1, control). (C) Actin polymerization in the presence of 0.5-, 1-, 2-, 4-, 6-,
8- and 10-fold molar excess of peptide 11 over G-actin (2 mm) (curves 2±8, respectively; curve 1, control). (D) Percentage of inhibition of actin
polymerization at different molar ratios of peptide 6 (W) and peptide 11 (X) to G-actin estimated from the slopes of the curves during the first 5 min
of polymerization. Values for peptides 6 and 11 are calculated from the curves shown in (B,C). Curves are representative of three to five independent
experiments.
Table 1. Peptides derived from murine HSP25. Peptide 1 represents
the N-terminus and peptide 22 the C terminus of HSP25. Peptides are
synthesized as 15-mers with the exception of peptides no. 1, 2 and 10,
























Fig. 2. Influence of murine HSP25 peptide 11 on actin polymer-
ization analysed by electron microscopy. Actin polymerization
(1.2 mm G-actin) in the absence (A) and in the presence of a 20-fold
molar excess of peptide 11 (B).
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the slopes of the curves obtained within 5 min of initializ-
ing the reaction. Curve 1 (peptide 11) and curve 2 (peptide
6) reveal that 50% inhibition of actin polymerization is
achieved at peptide to G-actin ratios of 2.5 : 1 and 10 : 1,
respectively.
To verify that the spectrofluorometric data reflect inhibi-
tion of formation of actin filaments, electron microscopic
experiments were performed in parallel. As shown in con-
trol experiments without peptide (Fig. 2A), actin filaments
of several micrometers length are loosely distributed
in the G-actin background, whereas in the presence of a
10-fold molar excess of peptide 11 no actin filaments are
observed (Fig. 2B). The same result was obtained when
using a 20-fold molar excess of peptide 6 (not shown).
Thus, the spectrofluorometric data are confirmed by elec-
tron microscopy.
Inhibition of actin polymerization by variants of murine
HSP25-derived peptide 11
Further studies were performed with modifications of the
most effective peptide 11 of murine HSP25. To analyse
whether the amino acid composition of peptide 11,
irrespective of the position of each amino-acid residue, or
the specific position of each residue determines its inter-
action with actin, a scrambled control peptide (Table 2,
peptide 11c) was synthesized. In designing this peptide,
amino-acid residues known for their ability to participate in
specific secondary structural elements were exchanged in
their position. When using this peptide at 20-fold molar
excess over G-actin, no effect on actin polymerization was
observed (data not shown) indicating the specificity of the
interaction of peptide 11 with actin.
In the following study, peptide 11 was modified by
deleting amino-acid residues from both the N- and the
C-terminus to identify residues involved in interaction with
actin. Results of experiments carried out with these pep-
tides in the actin polymerization assay are shown partially
in Fig. 3A and summarized in Table 2 (abbreviations used
for these peptides are also indicated in Table 2). Stepwise
deletion of the first three amino-acid residues IRQ from
the N-terminus of peptide 11 (peptides 11DN1, 11DN2,
11DN3) gradually reduced its activity to < 25%, < 5% and
0%, respectively (peptide 11DN3 see Fig. 3A, curve 2).
Surprisingly, deletion of the first six amino-acid residues
IRQTAD (peptide 11DN6) partially restored the inhibitory
activity, resulting in < 20% activity compared with peptide
11 (Fig. 3A, curve 6). The increased inhibitory activity of
peptide 11DN6 compared to peptide 11DN3 suggests that
the amino-acid residues TAD function as a linker between
Table 2. Compilation of various peptide 11-related sequences used in the actin polymerization assay. Peptides were derived from murine
HSP25 and aB-crystallin sequences. A number of peptides was obtained by N- and C-terminal deletion and by N-terminal extension of peptide
11-related sequences (see also Fig. 3). Residue numbers indicate N- and C-terminal positions of the peptides in the amino-acid sequence of the
protein. S indicates serines that are phosphorylated in the corresponding peptides (P). Activity of the peptides is related to that of the HSP25
peptide 11 which is set to 100% (see also Fig. 4). Numbers in parentheses refer to phosphorylated peptides.
Peptide Residues Sequence Activity
11 92±106 IRQTADRWRVSLDVN 100
11aB 68±82 MRLEKDRFSVNLDVK 0
11c ± TWLQRDANVRDISRV 0
11DN1 93±106 RQTADRWRVSLDVN 25
11DN2 94±106 QTADRWRVSLDVN 5
11DN3 95±106 TADRWRVSLDVN 0
11DN6 98±106 RWRVSLDVN 20
11DN9 101±106 VSLDVN 5
11DC4 92±102 IRQTADRWRVS 10
11DC6 92±100 IRQTADRWR 5
11DC8 92±98 IRQTADR 0
11DN4DC3 96±103 ADRWRVSL 0
111N16(P) 76±106 AFSRALNRQLSSGVSEIRQTADRWRVSLDVN 50 (25)
11aB1N16(P) 53±82 SFLRAPSW-IDTGLSEMRLEKDRFSVNLDVK 50 (25)
Fig. 3. Influence of various peptide 11 sequences on actin poly-
merization monitored by fluorescence spectroscopy. (A) Actin
polymerization in the absence (curve 1) or presence of a 40-fold
molar excess each of peptide 11DN3 (curve 2), 11DC6 (curve 3),
11DN9 (curve 4), 11DC4 (curve 5) and 11DN6 (curve 6) to G-actin.
(B) Actin polymerization in the absence (curve 1) or presence of a
10-fold molar excess to G-actin each of peptide 111N16P (curve 2),
peptide 11aB1N16P (curve 3), peptide 11aB1N16 (curve 4) and
peptide 111N16 (curve 5). In each case 2 mm G-actin were used.
Curves are representatives of three to five independent experiments.
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two terminal motifs the coordination of which is necessary
for an effective inhibition of actin polymerization (see
Discussion). After deletion of the N-terminal amino-acid
residues IRQ, this linker sequence seems to flex freely and
thus to hinder sterically binding of peptide 11DN3, thereby
reducing the inhibitory activity of the peptide in the actin
polymerization assay. Deletion of the linker residues TAD
from this peptide, however, resulted in improved binding
and increased inhibitory activity. Further deletion from the
N-terminus comprising the residues IRQTADRWR (peptide
11DN9) decreased the inhibitory activity to < 5% com-
pared with peptide 11 (Fig. 3A, curve 4). In comparison,
deletion of amino-acid residues from the C-terminus of
peptide 11 was slightly less effective in reducing the
inhibitory activity of peptide 11. Deletion of the residues
LDVN (peptide 11DC4) and VSLDVN (peptide 11DC6)
reduced the inhibitory activity to < 10% and < 5%,
respectively, of that of peptide 11 (Fig. 3A, curves 5 and
3). Further deletion from the C-terminus comprising the
residues WRVSLDVN (peptide 11DC8) completely abol-
ished the inhibitory activity of peptide 11. Also no
inhibitory activity displayed a peptide where both the N-
and the C-termini were deleted (11DN4DC3).
These data indicate that both the N-terminal (IRQ) and
the C-terminal (WRVSLDVN) amino-acid residues of
peptide 11 are involved in its inhibitory activity. For full
activity, however, both the N- and the C-termini are required.
That each terminus per se is not sufficient for an effective
inhibitory activity is supported by the fact that the sequences
IRQ and SLVDN are also included in the neighbouring
peptides 10 and 12, which were inactive.
Because of the reported interaction of the closely related
sHSP aB-crystallin with actin (see Introduction), an
aB-crystallin-derived peptide corresponding to peptide 11
of HSP25 was synthesized (peptide 11aB). Its sequence
was defined by sequence alignment of murine HSP25 and
aB-crystallin as shown in Fig. 4. However, peptide 11aB
had no effect on actin polymerization when used at 20-fold
molar excess to actin and was inactive even at 40-fold
molar excess (data not shown).
Phosphorylation affects the activity of HSP25- and
aB-crystallin-derived peptides
Phosphorylation upon stress is one of the most prominent
features of sHSPs, and it is known that phosphorylation of
HSP25 modulates its effect on actin polymerization (see
Discussion). To analyse the effect of phosphorylation on the
actin polymerization inhibitory activity of HSP25- and
aB-crystallin-derived peptides, we took advantage of the
fact that some of the phosphorylation sites of these proteins
are located N-terminally in close vicinity to peptide 11 (or
the corresponding aB-crystallin-derived peptide; see Fig. 4).
Therefore, the N-terminally extended HSP25-derived peptide
(111N16) as well as the aB-crystallin-derived peptide
(11aB1N16) were synthesized. These peptides include
known phosphorylation sites at S86 (murine HSP25 [11]);
and S59 (murine aB-crystallin [9,13]); (see Table 2 and
Fig. 4). From each peptide, the unphosphorylated as well
as the phosphorylated form (111N16P, 11aB1N16P) were
synthesized. As shown in Fig. 3B, the unphosphorylated
HSP25 peptide 111N16 (curve 5) inhibited actin polymer-
ization effectively at 10-fold molar excess over G-actin, with
< 50% of the inhibitory activity of peptide 11 (Table 2, cf.
Fig. 1B). Reduced efficacy of peptide 111N16 compared
with peptide 11 may be due to higher flexibility of the
N-terminal region of the molecule which may sterically
hinder proper binding to actin (see Discussion). When the
phosphorylated form of this peptide, 111N16P, was used,
the activity was reduced to < 25% compared with peptide 11
(a 50% reduction in inhibitory activity compared with
peptide 111N16) (Fig. 3B, curve 2). Interestingly, in
contrast with peptide 11aB, also the N-terminally extended
form of the aB-crystalline peptide, 11aB1N16, demon-
strated an inhibitory effect on actin polymerization (Fig. 3B,
curve 4), which was comparable to the effect of the
homologous HSP25-derived peptide (Table 2). Moreover,
the activity was reduced when the phosphorylated form of
this peptide, 11aB1N16P, was used (Fig. 3B, curve 3), the
extent of reduction again being comparable to that of the
homologous HSP25 peptide 111N16P (Table 2). These data
are remarkable in two aspects: (a) synthetic peptides derived
from N-terminally extended peptide 11-like sequences of
aB-crystallin inhibit actin polymerization in vitro like those
of HSP25; and (b) phosphorylation of these peptides results
in a reduction of their actin polymerization inhibitory
activity. This behaviour is similar to that of intact native
HSP25 (cf [8]).
D I S C U S S I O N
This study provides the first evidence for a direct inter-
action of defined sequence segments of the small heat
shock proteins HSP25 and aB-crystallin with actin thus
specifying previous results about the function of HSP25 as
inhibitor of actin polymerization [22] and implying a
similar function for aB-crystallin. In particular, two regions
of murine HSP25 have been identified which inhibit
polymerization of actin effectively in vitro. Synthetic pep-
tides comprising these sequences (peptides 6 and 11) inhibit
actin polymerization half maximally at 10- and 2.5-fold
molar excess over G-actin, respectively, compared with 0.1-
to 0.2-fold molar excess of the isolated protein [8,22]. Thus,
10- to 100-fold higher amounts of the peptides are neces-
sary to exert the same effects as the native protein. Similar
relationships in inhibition of actin polymerization between
actin-binding peptides and intact proteins have been
described for other proteins: about 10-fold higher amounts
of the actin-binding dodecapeptide of cofilin, an F-actin
Fig. 4. Alignment of HSP25 and aB-crystallin sequences. Asterisks
in the consensus line indicate identical amino-acid residues, colons
indicate conserved substitutions and dots indicate semiconserved
substitutions. Arrows indicate the phosphorylation sites of HSP25
(double arrow) and aB-crystallin (arrow). Sequences of peptide 6 and
extended peptide 11 are shown in bold letters. The N-terminus of the
a-crystallin domain is marked by an asterisk. Sequences are from
murine HSP25 (GenBank Accession Number P14602) and murine
aB-crystallin (GenBank Accession Number P23927).
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side-binding and depolymerizing protein [37], and the
actin-binding 30-residue fragment of thymosin b4, a
G-actin sequestering protein [38], are necessary to achieve
the same extent of inhibition as the intact protein. Lower
efficacy of peptides compared with whole proteins may be
due to the fact that peptides in general show a lower degree
of higher ordered structure which may result in lower
binding affinity, whereas in the whole protein these
sequence segments are stabilized by neighbouring sequence
elements and by interaction with other protein domains.
The inhibitory effect of murine HSP25 peptide 11 on actin
polymerization is < 10-fold and threefold higher than that
of the cofilin- [37] and thymosin b4-derived peptides [38].
Similarly, the inhibitory activity of murine HSP25 peptide
11 is about sixfold higher than that of a peptide (27-mer)
derived from actin binding protein (ABP-120), an actin
filament cross-linking protein of Dictyostelium discoideum,
which displays 50% inhibition of actin polymerization at a
14-fold molar excess of the peptide over G-actin [39].
Furthermore, an actin-binding peptide (30-mer) derived
from the N-terminus of actobindin from Acanthamoeba
castellani was found to cause 50% inhibition of actin
polymerization at about sevenfold molar excess of the
peptide over G-actin [38], thus being three times less
effective than the murine HSP25-derived peptide 11.
Hence, HSP25-derived peptides 6 and 11 belong to the
most active peptides inhibiting actin polymerization
according to our knowledge.
Sequence comparison with actin-binding sites of other
proteins reveals that no sequence homology exists between
the HSP25-and aB-crystallin-derived peptides with actin
polymerization inhibiting activity and the above-mentioned
actin-binding dodecapeptide of cofilin and homologous
sequences in the related proteins destrin, ADF and depactin
[37]. Furthermore, no sequence similarity has been found to
the actin-binding site of ABP-120, a conserved sequence
which is also found in a-actinin, b-spectrin, dystrophin and
fimbrin [39]. The same is true for the actin-binding sites of
actobindin and thymosin b4 [38], the b subunit of CapZ
[40] and proteins of the ezrin family [41]. Moreover, the
actin-binding hexapeptide motif present in actobindin and
thymosin b4 which also exists in a number of other actin-
binding proteins like a-actinin, fimbrin, plastin, villin,
myosin heavy chain and tropomyosin [42] is not found in
HSP25 and aB-crystallin. Thus, sHSPs seem to represent a
new family of actin-binding proteins. This interpretation is
supported by recent results indicating that a further sHSP,
rat HSP20, associates with actin [43].
The data about the inhibitory activity of HSP25-derived
peptides can be correlated with data about the crystal
structure of HSP16.5, a homologous sHSP from the
archaebacterium Methanococcus jannaschii [44]. As evi-
dent from the crystal structure, the region homologous to
peptide 11 of HSP25 is composed of two b strands in
antiparallel orientation (b2, b3 in HSP16.5) connected by a
turn of three amino-acid residues. Interestingly, this turn
corresponds to residues TAD of murine peptide 11 proposed
to act as a linker between the identified N- and C-terminal
motifs involved in actin binding (see Results). It is very
likely that this proposed linker sequence allows peptide 11
to adopt a conformation, which enables appropriate inter-
action with the actin molecule. Furthermore, it can be
concluded from the crystal structure of Hsp16.5 that the
region of the extended peptide 11 is most probably involved
in intersubunit contacts in high molecular weight com-
plexes of HSP25 as several of the amino-acid residues
located in the homologous region of HSP16.5 (S31 to P61)
contribute to contacts between subunits along the twofold
axis of the complexes (see Kim et al. [44]). The region
homologous to the HSP25-derived peptide 6, however, is
missing from HSP16.5. According to the crystallographic
data the N-terminus of HSP16.5 is located in the interior of
the high molecular weight complexes, and it is likely that
this also applies for the N-terminal region of HSP25. Thus,
in high molecular weight complexes of HSP25 the amino-
acid residues of peptides 6 and 11 are most probably buried
and not accessible to interact with actin. In contrast, in
HSP25 monomers these regions seem to be accessible and
consequently they may interact with actin. This confirms
previous results which indicated that only HSP25 mono-
mers but not high molecular weight complexes of HSP25
inhibit actin polymerization in vitro [8].
Comparison of the inhibitory activity of peptides derived
from homologous sequences of HSP25 and aB-crystallin
showed a comparable extent of inhibition by the N-termin-
ally extended peptides 111N16. These data suggest that not
only HSP25, but also aB-crystallin acts as an inhibitor of
actin polymerization and that the activity of both proteins is
at least partially mediated by these sequence segments. The
lower efficacy of peptide 111N16, compared with peptide
11, is likely to have the same causes as discussed above.
Based on the crystal structure of HSP16.5 ([44], and see
above), it can be concluded that the N-terminus of peptide
111N16 contains a short b strand (b1) and is partially
unstructured. As b1 belongs to another b sheet than b2 and
b3 of peptide 11, it is very unlikely that peptide 111N16
can adopt the correct tertiary structure present in the whole
protein. Protection of binding sites and/or sterical hindrance
by the flexible N-terminus of the 32-mer could result in
lower efficacy of peptide 111N16 compared with peptide
11. Differences in the inhibitory potential of the HSP25-
derived peptide 11 and the aB-crystallin-derived peptide
11aB, on the other hand, may reflect cell-type specific
mechanisms of regulation of the actin-binding ability of
HSP25 and aB-crystallin which may occur through the
interaction with different sHSP-binding proteins discovered
recently [26,45]. Differential location of both proteins in rat
and human heart [21] and rat kidney [46] supports this view.
Another interesting result described here is the reduced
inhibitory activity of phosphorylated vs. unphosphorylated
HSP25- and aB-crystallin peptides. This finding confirms
previous results obtained with native murine HSP25 in vitro
showing that unphosphorylated but not phosphorylated
HSP25 monomers inhibit actin polymerization [8]. Further-
more, there is growing evidence about phosphorylation-
dependent effects of HSP25 on the organization of
microfilaments in vivo. Transfection or microinjection of
different cell types with wild-type or nonphophorylatable
HSP25 demonstrated, that only wild-type HSP25 protected
the microfilament network against the deleterious effects of
hyperthermia [24,30], cytochalasin D [24], free oxygen
radicals [47] and cholecystokinin[48]. Protein phosphatase
inhibitors and heat preconditioning were shown to prevent
HSP25 dephosphorylation and F-actin disruption [29,49].
Pinocytosis activity [25], amount of membrane-associated
F-actin [27] and cell migration [28] were shown to depend
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on the presence of phosphorylatable HSP25. Obviously,
phosphorylation of HSP25 is a prerequisite for rapid
modulation of the actin cytoskeleton.
In comparison, data about interaction of aB-crystallin
with actin are more rare. It was demonstrated previously
that aB-crystallin colocalizes with microfilaments in cul-
tured lens cells [50] and with the I-band of myofibrils
in cardiomyocytes of rat and human heart [21]. Further-
more, aB-crystallin was found to bind to actin by affinity
chromatography [16,17] and cosedimentation assays [17].
In addition, antisense experiments showed a disorganized
microfilament network in cultured glial cells after reduction
of aB-crystallin expression [19]. With respect to the influ-
ence of phosphorylation on the interaction of aB-crystallin
with actin it was described that phosphorylated aB-crystallin
was less effective in suppression of cytochalasin-induced
depolymerization of actin filaments than the unphosphory-
lated form [20], in this respect aB-crystallin being compar-
able to HSP25. These findings are in accordance with our
results on the interaction of aB-crystallin-derived peptides
with actin and the regulation of their activity by phos-
phorylation. Interestingly, the different phosphorylation
sites of aB-crystallin are phosphorylated by different
kinases, and only S59, which is included in the extended
peptide 11 tested in our assays, is phosphorylated by
MAPKAP kinase-2 [51], which also phosphorylates the
homologous phosphorylation site S86 in murine HSP25
[52]. Furthermore, it was shown that phosphorylation of
aB-crystallin and HSP25 occurs in response to similar
stressors in HeLa cells [53]. Obviously, in accordance with
our in vitro results, regulation of the interaction of HSP25
and aB-crystallin with actin in vivo seems to occur through
the same signal transduction cascade(s). Finally, it should
be mentioned that regulation of activity by phosphorylation
has also been observed for several other actin-binding
proteins, e.g. synapsin [54], caldesmon [55], actin depoly-
merizing factor [56] and cofilin [57] which are unable to
bind to actin in their phosphorylated states.
In conclusion, this work provides the first data about the
molecular mechanism of the interaction of the small heat
shock proteins HSP25 and aB-crystallin with actin. It
describes actin-binding sites involved in inhibition of actin
polymerization and provides data implying that the actin-
polymerization inhibiting activity of both proteins is
reduced by phosphorylation. Thus, HSP25 and aB-crystallin
are characterized as actin-binding proteins the activity of
which is regulated by phosphorylation, a feature that may
also apply to other sHSPs.
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